Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Molecular Weight | 847.0 g/mol |
---|---|
Molecular Formula | C46H62N4O11 |
XLogP3 | 6.3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 5 |
Exact Mass | 846.44150881 g/mol |
Monoisotopic Mass | 846.44150881 g/mol |
Topological Polar Surface Area | 206 A^2 |
Heavy Atom Count | 61 |
Formal Charge | 0 |
Complexity | 1870 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Mycobutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 4 | |
---|---|
Drug Name | Rifabutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Lupin |
3 of 4 | |
---|---|
Drug Name | Rifabutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Lupin |
4 of 4 | |
---|---|
Drug Name | Mycobutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?